PREIMPLANTATION GENETIC TESTING PODCAST
Preimplantation Genetic Testing Podcast: Dr. Gary Harton
Listen to the It’s In Our Blood podcast recorded by Pathology Technology Australia. In this podcast Dr. Harton describes the basic concept of preimplantation genetic testing and the current and likely future utilization of the technology. He gives a general overview of how embryos are tested and describes how small throughput systems make testing open to more labs. Finally, non-invasive testing on spent culture media is also covered.
Dr. Gary Harton
Dr. Harton received his Bachelor of Science degree from James Madison University and his Ph.D. at the University of Kent, Canterbury, UK. His thesis title was Facilitating the widespread use of preimplantation genetic diagnosis and screening through best practice and novel technology development.
After 20+ years serving in various roles, including both clinical laboratory and management positions, he began his commercial career performing Business Development and Market Development roles with two prominent genetics companies, a fertility start up and a large reference genetics laboratory. Gary has been involved in a number of exciting breakthroughs in the field of reproductive genetics including performing the first clinical preimplantation genetic diagnosis (PGD) for an autosomal dominant disease (Marfan syndrome) and performing the first clinical PGD for spinal muscular atrophy (SMA). In addition, Dr. Harton was involved in the team that pioneered non-disclosing Huntington disease PGD where a patient at risk for HD could ensure that their children were free from the mutation without discovering their own HD status. He was also involved in the team that discovered and patented Karyomapping, a revolutionary new technology allowing practically any genetic defect to be diagnosed in embryos using one single array-based test.
Dr. Harton is certified by the American Board of Bioanalysis (ABB) as a Technical Supervisor, in Molecular Diagnostics and is a member of the American Society for Reproductive Medicine (ASRM) as well as the European Society of Human Reproduction and Embryology (ESHRE), and Preimplantation Genetic Diagnosis International Society. Dr. Harton is currently a member of the board of directors for PGD-IS, and a member of the Special Advisory Group for UK-NEQAS which performs external quality assessment schemes for preimplantation genetics. He has also served as Chair of the Steering Committee for the ESHRE PGD and has been an author on numerous peer reviewed scientific articles, abstracts and book chapters as well.
For research use only. Not for use in diagnostic procedures.